Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. (Q29417082)

From Wikidata
Revision as of 04:40, 21 May 2019 by Sic19 (talk | contribs) (‎Added qualifier: series ordinal (P1545): 80, #quickstatements; batch #13063 by User:Sic19)
Jump to navigation Jump to search
scientific article
Language Label Description Also known as
English
Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility.
scientific article

    Statements

    Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    Walter Maksymowych
    Spondyloarthritis Research Consortium of Canada (SPARCC)
    Jacome Bruges-Armas
    Carlos Lopez-Larrea
    Antonio López-Vázquez
    Jenefer M Blackwell
    Suzannah J Bumpstead
    Alagurevathi Jayakumar
    Radhi Ravindrarajah
    Ananth C Viswanathan
    Australo-Anglo-American Spondyloarthritis Consortium (TASC)
    Wellcome Trust Case Control Consortium 2 (WTCCC2)

    Identifiers